QurCan Therapeutics Inc.
ID: 13467259Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.
1
Funding Rounds
$3.0m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Sh***** Wu |
|
- | - |
| Mo****** Am*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Sh***** Wu |
|
- | - |
| Mo****** Am*** | - | - |
Funding series
Funding Series Analysis
The company QurCan Therapeutics Inc. has raised a total of $3m in funding over 1 rounds.
Key Insights:
- QurCan Therapeutics Inc. Seed round, March 17, 2021: $3m